Last reviewed · How we verify
AstroStem
AstroStem is a stem cell therapy that aims to repair damaged tissues and promote regeneration.
AstroStem is a stem cell therapy that aims to repair damaged tissues and promote regeneration. Used for Treatment of ischemic stroke.
At a glance
| Generic name | AstroStem |
|---|---|
| Also known as | Autologous Adipose Tissue Derived Mesenchymal Stem Cells |
| Sponsor | Nature Cell Co. Ltd. |
| Drug class | Stem cell therapy |
| Modality | Small molecule |
| Therapeutic area | Regenerative medicine |
| Phase | Phase 2 |
Mechanism of action
AstroStem works by introducing healthy stem cells into the body, which then differentiate into specific cell types to replace damaged or diseased cells. This process is thought to be mediated by various signaling pathways and growth factors that promote tissue repair and regeneration.
Approved indications
- Treatment of ischemic stroke
Common side effects
- Graft-versus-host disease
- Infection
- Tumor formation
Key clinical trials
- Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia (PHASE1, PHASE2)
- Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease (PHASE2)
- A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease (PHASE1, PHASE2)
- Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP (EARLY_PHASE1)
- Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AstroStem CI brief — competitive landscape report
- AstroStem updates RSS · CI watch RSS
- Nature Cell Co. Ltd. portfolio CI